STOCK TITAN

Maverick Capital/Ainslie Hold 10.23M IVVD Shares (8.5%)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

This Schedule 13G/A discloses that Maverick Capital, Ltd., Maverick Capital Management, LLC and Lee S. Ainslie III report beneficial ownership of 10,229,118 shares of Invivyd, Inc., representing 8.5% of the 119,961,445 outstanding shares reported as of May 1, 2025. The filing identifies the shares as held for Maverick clients across five funds: Maverick Fund USA, Ltd. (2,253,369), Maverick Fund II, Ltd. (2,210,410), Maverick Long Enhanced Fund, Ltd. (2,419,202), Maverick HP, L.P. (2,139,246) and Maverick Long Fund, Ltd. (1,206,891).

Each reporting person states shared voting and dispositive power over these shares and no sole voting or dispositive power. The document is filed as a Schedule 13G 08/14/2025.

Positive

  • Beneficial ownership reported: 10,229,118 shares of Invivyd, representing 8.5% of outstanding stock.
  • Detailed fund-level disclosure: Shares are itemized across five Maverick funds with specific share counts.

Negative

  • None.

Insights

TL;DR: Maverick reports a material passive stake of 8.5% (10.23M shares) in Invivyd; ownership is held across five funds.

The Schedule 13G/A shows a material stake above the 5% reporting threshold: 10,229,118 shares or 8.5% of the 119,961,445 shares outstanding as of May 1, 2025. The filing attributes the shares to specific Maverick funds with share-level breakdowns, and reports only shared voting and dispositive power, not sole control. Because this is a 13G filing

TL;DR: Reporting structure indicates collective advisory control but no unilateral authority; certification denies takeover intent.

The filing names three reporting persons—Maverick Capital, Maverick Capital Management and Lee S. Ainslie III—and records shared voting and dispositive power of 10,229,118 shares while showing 0 sole voting or dispositive power. The use of Schedule 13G






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Maverick Capital, Ltd.
Signature:/s/ Trevor Wiessmann*
Name/Title:By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Date:08/14/2025
Maverick Capital Management, LLC
Signature:/s/ Trevor Wiessmann*
Name/Title:Lee S. Ainslie III, Manager
Date:08/14/2025
Lee S. Ainslie III
Signature:/s/ Trevor Wiessmann*
Name/Title:Lee S. Ainslie III, Manager
Date:08/14/2025

Comments accompanying signature: Under Power of Attorney, dated March 15, 2018

FAQ

What stake does Maverick report in Invivyd (IVVD)?

The filing reports beneficial ownership of 10,229,118 shares, representing 8.5% of Invivyd's outstanding common stock.

Who filed the Schedule 13G/A for IVVD?

The filing was made on behalf of Maverick Capital, Ltd., Maverick Capital Management, LLC and Lee S. Ainslie III.

Are these shares held with sole or shared voting power?

The reporting persons state 0 shares of sole voting or dispositive power and 10,229,118 shares of shared voting and dispositive power.

Is this an activist filing (Schedule 13D) or passive (Schedule 13G)?

This is filed as a Schedule 13G , indicating the position is reported under passive-investor rules and not as an activist 13D filing.

On what outstanding-share base is the 8.5% calculated?

The percentage is based on 119,961,445 outstanding shares of common stock reported by the issuer as of May 1, 2025.

When was the filing signed?

The Schedule 13G/A signatures are dated 08/14/2025 (signed under a Power of Attorney dated March 15, 2018).
Invivyd

NASDAQ:IVVD

IVVD Rankings

IVVD Latest News

IVVD Latest SEC Filings

IVVD Stock Data

733.17M
223.47M
19.2%
60.75%
2.52%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
NEW HAVEN